Tai‐Chung Lam

1.1k total citations
33 papers, 488 citations indexed

About

Tai‐Chung Lam is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Clinical Psychology. According to data from OpenAlex, Tai‐Chung Lam has authored 33 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 7 papers in Clinical Psychology. Recurrent topics in Tai‐Chung Lam's work include Glioma Diagnosis and Treatment (6 papers), Cancer survivorship and care (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Tai‐Chung Lam is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Cancer survivorship and care (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Tai‐Chung Lam collaborates with scholars based in Hong Kong, China and United States. Tai‐Chung Lam's co-authors include Chi‐Leung Chiang, Cheuk‐Wai Choi, Wing‐Lok Chan, Paul S. F. Yip, Victor Lee, Ka On Lam, Chia‐Chin Lin, Feng‐Ming Kong, Denise Shuk Ting Cheung and Yi Chai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Tai‐Chung Lam

33 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tai‐Chung Lam Hong Kong 12 221 168 72 61 53 33 488
Vittorio Mattioli Italy 15 379 1.7× 227 1.4× 80 1.1× 59 1.0× 17 0.3× 21 751
David Mizrahi Australia 15 541 2.4× 100 0.6× 91 1.3× 19 0.3× 35 0.7× 44 875
T. Yau China 12 303 1.4× 107 0.6× 41 0.6× 44 0.7× 16 0.3× 18 504
Bhupesh Parashar United States 13 108 0.5× 133 0.8× 74 1.0× 23 0.4× 65 1.2× 55 461
Dominique Lejeune United States 14 106 0.5× 129 0.8× 20 0.3× 17 0.3× 26 0.5× 64 570
Fabrizio Artioli Italy 18 497 2.2× 358 2.1× 28 0.4× 27 0.4× 35 0.7× 49 966
Hiroko Okinaga Japan 16 80 0.4× 44 0.3× 59 0.8× 21 0.3× 73 1.4× 55 719
Tarık Demir Türkiye 11 90 0.4× 48 0.3× 30 0.4× 51 0.8× 14 0.3× 41 333
Marlies Peters Netherlands 17 573 2.6× 202 1.2× 14 0.2× 42 0.7× 19 0.4× 33 1.1k
Vanessa Potter United Kingdom 15 291 1.3× 174 1.0× 32 0.4× 9 0.1× 19 0.4× 29 666

Countries citing papers authored by Tai‐Chung Lam

Since Specialization
Citations

This map shows the geographic impact of Tai‐Chung Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tai‐Chung Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tai‐Chung Lam more than expected).

Fields of papers citing papers by Tai‐Chung Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tai‐Chung Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tai‐Chung Lam. The network helps show where Tai‐Chung Lam may publish in the future.

Co-authorship network of co-authors of Tai‐Chung Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Tai‐Chung Lam. A scholar is included among the top collaborators of Tai‐Chung Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tai‐Chung Lam. Tai‐Chung Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pu, Jenny Kan-Suen, Lai‐Fung Li, Danny Chan, et al.. (2025). Impact of alternating electric fields therapy for newly diagnosed WHO grade 4 astrocytoma on patient survival: a real-world propensity-score adjusted prospective multicenter study. Journal of Neuro-Oncology. 173(2). 317–330. 1 indexed citations
2.
Chiang, Chi‐Leung, Tai‐Chung Lam, Aya El Helali, et al.. (2023). Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial. The Lancet Regional Health - Western Pacific. 40. 100898–100898. 7 indexed citations
4.
Hu, Fang, Johanna Bertl, Xiaoqiang Zhu, et al.. (2022). Tumour mutational burden is overestimated by target cancer gene panels. SHILAP Revista de lepidopterología. 3(1). 56–64. 5 indexed citations
5.
Au, Philip Chun-Ming, Yeon‐Hee Baek, Ching‐Lung Cheung, et al.. (2022). Comparative Treatment Persistence with Bone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors: A Multinational Retrospective Cohort Study. BioDrugs. 36(3). 381–392. 4 indexed citations
6.
Kim, Ju Hwan, Philip Chun-Ming Au, Yeon‐Hee Baek, et al.. (2022). Bone-targeting agents in major solid tumour metastases: a multinational cohort study. BMJ Supportive & Palliative Care. 13(e3). e1064–e1073. 1 indexed citations
7.
Lam, Tai‐Chung, Cheuk‐Wai Choi, Victor Lee, et al.. (2021). Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure. Lung Cancer. 159. 18–26. 53 indexed citations
8.
Takemura, Naomi, Denise Shuk Ting Cheung, Dyt Fong, et al.. (2021). Relationship of subjective and objective sleep measures with physical performance in advanced-stage lung cancer patients. Scientific Reports. 11(1). 17208–17208. 2 indexed citations
9.
Lam, Tai‐Chung, et al.. (2021). Understanding the impact of clinical characteristics and healthcare utilizations on suicide among cancer sufferers: a case-control study in Hong Kong. The Lancet Regional Health - Western Pacific. 17. 100298–100298. 4 indexed citations
10.
Lau, Bobo Hi Po, Amy Yin Man Chow, Ting Kin Ng, et al.. (2020). Comparing the efficacy of integrative body-mind-spirit intervention with cognitive behavioral therapy in patient-caregiver parallel groups for lung cancer patients using a randomized controlled trial. Journal of Psychosocial Oncology. 38(4). 389–405. 16 indexed citations
11.
Chan, Wing‐Lok, Cheuk‐Wai Choi, Chi‐Leung Chiang, et al.. (2020). Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma. Advances in Radiation Oncology. 5(5). 880–888. 46 indexed citations
12.
Lam, Tai‐Chung, Xian Chen, Li Yang, et al.. (2020). Quality of end-of-life care of advanced cancer patients in mainland China—a retrospective cohort of 441 hospital-death in a public funded comprehensive hospital. Annals of Palliative Medicine. 9(6). 4514–4520. 3 indexed citations
13.
Emery, Clifton R., et al.. (2020). Suicidal/self-harm behaviors among cancer patients: a population-based competing risk analysis. Psychological Medicine. 52(12). 2342–2351. 11 indexed citations
14.
Lam, Tai‐Chung, K. Tsang, Victor Lee, et al.. (2020). 380MO A phase II trial of atezolizumab, bevacizumab, pemetrexed and carboplatin combination for metastatic EGFR-mutated NSCLC after TKI failure. Annals of Oncology. 31. S1389–S1389. 6 indexed citations
15.
Chai, Yi, Hao Luo, Gloria Hoi Yan Wong, et al.. (2020). Risk of self-harm after the diagnosis of psychiatric disorders in Hong Kong, 2000–10: a nested case-control study. The Lancet Psychiatry. 7(2). 135–147. 41 indexed citations
17.
Prasanna, Prateek, Lisa R. Rogers, Tai‐Chung Lam, et al.. (2019). Disorder in Pixel-Level Edge Directions on T1WI Is Associated with the Degree of Radiation Necrosis in Primary and Metastatic Brain Tumors: Preliminary Findings. American Journal of Neuroradiology. 40(3). 412–417. 13 indexed citations
18.
Lam, Tai‐Chung, Arjun Sahgal, Simon S. Lo, & Eric L. Chang. (2017). An update on radiation therapy for brain metastases. Chinese Clinical Oncology. 6(4). 35–35. 4 indexed citations
19.
20.
Lam, Tai‐Chung, Arjun Sahgal, Eric L. Chang, & Simon S. Lo. (2014). Stereotactic radiosurgery for multiple brain metastases. Expert Review of Anticancer Therapy. 14(10). 1153–1172. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026